Search results
FTC Moves to Allow Generic Versions of Ozempic
Futurism via Yahoo Finance· 59 minutes agoThe Federal Trade Commission is seeking to clear the path for generic Ozempic — but there will be a long road ahead before cheaper versions of the...
Is Wegovy or Ozempic Better for Weight Loss?
MediaFeed via AOL· 58 minutes agoOzempic: What’s the Difference? Ozempic is approved by the FDA (U.S. Food and Drug Administration) to help patients with type 2 diabetes control their...
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 16 hours agoTandem Diabetes Care (TNDM) delivered earnings and revenue surprises of 21.25% and 10.76%,...
Q1 2024 Tandem Diabetes Care Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 hours agoParticipants John F. Sheridan; President, CEO & Director; Tandem Diabetes Care, Inc. Leigh A. Vosseller; Executive VP, CFO & Treasurer; Tandem Diabetes ...
Tandem Diabetes Care (TNDM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks via Yahoo Finance· 15 hours agoThe headline numbers for Tandem Diabetes Care (TNDM) give insight into how the company performed in...
Why a legal fight against the manufacturers of Ozempic, Mounjaro, and other diabetes and weight-loss...
Philly.com· 1 day agoThe patients live all over the country, but the lawsuits that play out in a Philadelphia courtroom...
This Is a Huge Sigh of Relief for Novo Nordisk Investors
Motley Fool via Yahoo Finance· 3 hours agoNovo Nordisk's (NYSE: NVO) success hinges on two key products: Ozempic and Wegovy. The former is a ...
Mexico questions three people over missing American and Australian tourists
CNN.com· 3 hours agoAmerican Jack Carter Rhoad and Australian brothers Jake and Callum Robinson were reported missing on...
Tandem Diabetes Care Shares Rise 17% on Raised 2024 Sales Outlook
Market Watch· 3 hours agoBy Denny Jacob Tandem Diabetes Care shares rose 17% in premarket trading after it bumped up its adjusted sales outlook for 2024. Shares were trading around...
How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss...
Fortune via Yahoo Finance· 3 hours agoIndianapolis-based Eli Lilly (no. 142 on the Fortune 500) is the maker of Mounjaro, classified as...
